Computed tomographic colonography in subjects with positive faecal occult blood test refusing optical colonoscopy

Digestive and Liver Disease

Volumn 45, Issue 4, 2013, Pages 285-289

  Sali, Lapo ^a   Grazzini, Grazia ^b   Ventura, Leonardo ^b   Falchini, Massimo ^a   Borgheresi, Alessandra ^a   Castiglione, Guido ^b   Grimaldi, Michele ^a   Ianniciello, Nicola ^c   Mallardi, Beatrice ^b   Zappa, Marco ^b   Mascalchi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^c SAN GIOVANNI DI DIO HOSPITAL   (Italy)

Author keywords

Colonoscopy; Colorectal cancer screening; CT colonography; Faecal occult blood test

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SCREENING; CLINICAL TRIAL; COLONOSCOPY; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; COMPUTED TOMOGRAPHIC COLONOGRAPHY; COMPUTED TOMOGRAPHY SCANNER; FEMALE; HEALTH PROGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; OCCULT BLOOD TEST; PATIENT COMPLIANCE; PATIENT REFERRAL; POSTAL MAIL; PRIORITY JOURNAL; TREATMENT REFUSAL;

ADENOCARCINOMA; ADENOMA; AGED; COLONOGRAPHY, COMPUTED TOMOGRAPHIC; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; OCCULT BLOOD; PROSPECTIVE STUDIES; TREATMENT REFUSAL;

EID: 84875258570     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.11.008     Document Type: Article

References (31)

1. Ferlay J., Parkin D.M., Steliarova-Foucher E. Estimates of the cancer incidence and mortality in Europe in 2008. European Journal of Cancer 2010, 46:765-781.
2. Hewitson P., Glasziou P., Watson E., et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): an update. American Journal of Gastroenterology 2008, 103:1541-1549.
3. Council recommendation of 2 December 2003 on cancer screening. Official Journal of the European Union 2003, 2003/878/EC:34-8.
4. van Roosbroeck S., Hoeck S., Van Hal G. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies. Cancer Epidemiology 2012, [Epub ahead of print].
5. van Roon A.H.C., Hol L., van Vuuren A.J., et al. Are fecal immunochemical test characteristics influenced by sample return time? A population-based colorectal cancer screening trial. American Journal of Gastroenterology 2012, 107:99-107.
6. Zorzi M., Baracco S., Fedato C., et al. Screening for colorectal cancer in Italy, 2009 survey. Epidemiologia e Prevenzione 2011, 35:55-77.
7. van Rossum L.G., van Rijn A.F., Laheij R.J., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 2008, 135:82-90.
8. de Haan M.C., van Gelder R.E., Graser A., et al. Diagnostic value of CT-colonography as compared to colonoscopy in an asymptomatic screening population: a meta-analysis. European Radiology 2011, 21:1747-1763.
9. Regge D., Laudi C., Galatola G., et al. Diagnostic accuracy of computed tomographic colonography for the detection of advanced neoplasia in individuals at increased risk of colorectal cancer. Journal of the American Medical Association 2009, 301:2453-2461.
10. Liedenbaum M.H., van Rijn A.F., de Vries A.H., et al. Using CT colonography as a triage technique after a positive faecal occult blood test in colorectal cancer screening. Gut 2009, 58:1242-1249.
11. Sali L., Falchini M., Della Monica P., et al. CT colonography before colonoscopy in subjects with positive faecal occult blood test. Preliminary experience. Radiologia Medica 2010, 115:1267-1278.
12. van Gelder R.E., Birnie E., Florie J., et al. CT colonography and colonoscopy: assessment of patient preference in a 5-week follow-up study. Radiology 2004, 233:328-337.
13. Gluecker T.M., Johnson C.D., Harmsen W.S., et al. Colorectal cancer screening with CT colonography, colonoscopy, and double-contrast barium enema examination: prospective assessment of patient perceptions and preferences. Radiology 2003, 227:378-384.
14. Stoop E.M., de Haan M.C., de Wijkerslooth T.R., et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncology 2012, 13:55-64.
15. Liedenbaum M.H., de Vries A.H., Gouw C.I., et al. CT colonography with minimal bowel preparation: evaluation of tagging quality, patient acceptance and diagnostic accuracy in two iodine-based preparation schemens. European Radiology 2010, 20:367-376.
16. Grazzini G., Castiglione C., Ciabattoni C., et al. Colorectal cancer screening programme by faecal occult blood test in Tuscany: first round results. European Journal of Cancer Prevention 2004, 13:19-26.
17. Grazzini G., Visioli C.B., Facchini L., et al. I programmi di screening colorettale in Toscana. I Programmi di screening della regione Toscana. Dodicesimo rapporto annuale. Risultati e attività di ricerca (dati 2010) 2011, 61-83. Scientific Press, Firenze. P. Mantellini (Ed.).
18. Campanella D., Morra L., Delsanto S., et al. Comparison of three different iodine-based bowel regimens for CT colonography. European Radiology 2010, 20:348-358.
19. Zalis M.E., Barish M.A., Choi J.R., et al. CT colonography reporting and data system: a consensus proposal. Radiology 2005, 236:3-9.
20. Moss S.M., Campbell C., Melia J., et al. Performance measures in three rounds of the English bowel cancer screening pilot. Gut 2012, 61:101-107.
21. Peris M., Espinàs J.A., Muñoz L., et al. Lessons learnt from a population-based pilot programme for colorectal cancer screening in Catalonia (Spain). Journal of Medical Screening 2007, 14:81-86.
22. Shields H.M., Weiner M.S., Henry D.R., et al. Factors that influence the decision to do an adequate evaluation of a patient with a positive stool for occult blood. American Journal of Gastroenterology 2001, 96:196-203.
23. Baig N., Myers R.E., Turner B.R., et al. Physician-reported reasons for limited follow-up of patients with a positive fecal occult blood test screening results. American Journal of Gastroenterology 2003, 98:2078-2081.
24. Turner B., Myers R.E., Hyslop T., et al. Physician patient factors associated with ordering a colon evaluation after a positive fecal occult blood test. Journal of General Internal Medicine 2003, 18:357-363.
25. Nadel M.R., Shapiro J.A., Klabunde C.N., et al. A national survey of primary care physicians' methods for screening for fecal occult blood. Annals of Internal Medicine 2005, 142:86-94.
26. Myers R.E., Hyslop T., Gerrity M., et al. Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening. Cancer Epidemiology, Biomarkers and Prevention 1999, 8:587-593.
27. Yabroff K.R., Klabunde C.N., Myers R., et al. Physician recommendations for follow-up of positive fecal occult blood tests. Medical Care Research and Review 2005, 62:79-110.
28. Li C.M., Shiu M.N., Chia S.L., et al. Factors associated with referral compliance of abnormal immunochemical faecal occult blood test. Journal of Medical Screening 2007, 14:186-190.
29. Zheng Y.F., Saito T., Takahashi M., et al. Factors associated with intentions to adhere to colorectal cancer screening follow-up exams. BMC Public Health 2006, 6:272.
30. Taylor S.A., Slater A., Burling D.N., et al. CT colonography: optimisation, diagnostic performance and patient acceptability of reduced-laxative regimens using barium-based faecal tagging. European Radiology 2008, 18:32-42.
31. Rodger J., Steele R.J. Telephone assessment increases uptake of colonoscopy in a FOBT colorectal cancer-screening programme. Journal of Medical Screening 2008, 15:105-107.